Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell–driven B cell responses
Hyung W. Lim, Peter Hillsamer, Chang H. Kim
Hyung W. Lim, Peter Hillsamer, Chang H. Kim
View: Text | PDF | Erratum
Article Immunology

Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell–driven B cell responses

  • Text
  • PDF
Abstract

How Tregs migrate to GCs, and whether they regulate the helper activity of the T cells in GCs (GC-Th cells) remains poorly understood. We found a T cell subset in human tonsils that displays potent suppressive activities toward GC-Th cell–dependent B cell responses. These Tregs with the surface phenotype of CD4+CD25+CD69– migrate well to CCL19, a chemokine expressed in the T cell zone, but poorly to CXCL13, a chemokine expressed in the B cell zone. This migration toward the T cell–rich zone rapidly changes to trafficking toward B cell follicles upon T cell activation. This change in chemotactic behavior upon activation of T cells is consistent with their switch in the expression of the 2 chemokine receptors CXCR5 and CCR7. CD4+CD25+CD69– Tregs suppress GC-Th cells and GC-Th cell–induced B cell responses such as Ig production, survival, and expression of activation-induced cytosine deaminase. Our results have identified a subset of Tregs that is physiologically relevant to GC-Th cell–dependent B cell responses and a potential regulation mechanism for the trafficking of these Tregs to GCs.

Authors

Hyung W. Lim, Peter Hillsamer, Chang H. Kim

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
CD4+CD25+CD69– Tregs switch their expression pattern of chemokine recept...
CD4+CD25+CD69– Tregs switch their expression pattern of chemokine receptors and chemotactic responsiveness upon T cell activation. Tonsil mononuclear cells, freshly isolated or briefly activated for 10_14 hours with phytohemagglutinin (PHA) or for 5_10 hours with anti-CD3 and anti-CD28, were examined for their expression of chemokine receptors (A, B, and D) or for chemotactic responsiveness (C and E). In D, the chemokine receptors were examined by 1- or 2-step staining methods to avoid cross-reaction with the anti-CD3 and anti-CD28 antibodies used to activate the cells; these methods are less sensitive than the 3-step method used for A and B. The data obtained from 3 independent experiments were combined, and averages (and SEM in A) are shown. The background percent migration rates (averages and SEM, 3 experiments) for the 4 cell subsets were 23 ± 4.4 (CD4+CD25–CD69+), 16.3 ± 3.2 (CD4+CD25+CD69+), 23 ± 1.0 (CD4+CD25+CD69– Treg), and 11 ± 3.2 (CD4+CD25–CD69–). *Significant differences between the 2 samples. The P values were 0.024 (a), 0.042 (b), 0.032 (c), 0.019 (d), 0.045 (e), 0.033 (f), 0.041 (g), 0.002 (h), 0.049 (i), 0.021 (j), 0.023 (k), 0.009 (l), 0.004 (m), and 0.006 (n).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts